We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Radiochromatography Systems Assist Cancer Antibody Trials
News

Radiochromatography Systems Assist Cancer Antibody Trials

Radiochromatography Systems Assist Cancer Antibody Trials
News

Radiochromatography Systems Assist Cancer Antibody Trials

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Radiochromatography Systems Assist Cancer Antibody Trials"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The HPLC system incorporates an Agilent quaternary pump, an auto-degasser and a thermostatically controlled column compartment.  “We have had the equipment for ten months now, and it has proved to be a sensitive and reliable upgrade from our previous system,” says John Langford, head of the laboratory.
 
“It is always easy to use, whether we are measuring the gamma emissions of 111indium or the beta emissions of 90yttrium.  And the speed and ease of use of LabLogic’s Laura radiochromatography software means that results are available immediately after the end of each run.

“We often correlate our results to ITLC for confirmation, and here we’re finding that the LabLogic radio-TLC scanner provides more detail than the ‘cut and count’ method.  It makes it easier to locate peaks and discriminate between them and it uses the same Laura software, which is very convenient.”

Advertisement